Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
published : This month tags : Biotech-beach save search
Poseida Therapeutics Announces Strong Lineup of Presentations at the American Society of Gene and Cell Therapy 27th Annual Meeting
Published: 2024-04-18 (Crawled : 19:00) - biospace.com/
PSTX | News | $2.02 1.0% 0.99% 640K
|
Health Technology
|
| O: 0.25%
H: 0.0%
C: 0.0%
cell meeting therapeutics therapy
Nexcella, an Immix Biopharma Subsidiary, on Track to Dose NXC-201 Patients in United States
Published: 2024-04-18 (Crawled : 19:00) - biospace.com/
IMMX | News | $2.21 0.0% 64K
|
|
| O: -3.6%
H: 0.0%
C: 0.0%
nxc-201 biopharma
Acadia Pharmaceuticals Presents New DAYBUE™ (trofinetide) Clinical Data at the 2024 American Academy of Neurology (AAN) Annual Meeting
Published: 2024-04-17 (Crawled : 23:00) - biospace.com/
ACAD | $16.82 -1.47% -1.49% 3.5M
|
Health Technology
|
| O: 0.76%
H: 0.0%
C: 0.0%
neurology pharmaceuticals meeting
Poseida Therapeutics Hosts Gene Therapy R&D Day Highlighting New Scientific Advancements and Pipeline Focus
Published: 2024-04-17 (Crawled : 15:00) - biospace.com/
PSTX | News | $2.02 1.0% 0.99% 640K
|
Health Technology
|
| O: 0.0%
H: 2.46%
C: 0.49%
day pipeline therapeutics therapy
Evoke Pharma to Host Virtual Key Opinion Leader (KOL) Webinar on the Evolving Landscape of Gastroparesis
Published: 2024-04-17 (Crawled : 15:00) - biospace.com/
EVOK | $0.493 2.97% 2.88% 1.9K
|
Health Technology
| Email alert
Add to watchlist
pharma key
Sentynl Therapeutics Receives MHRA Authorization of NULIBRY® (fosdenopterin) for Treatment of MoCD Type A in Great Britain
Published: 2024-04-16 (Crawled : 16:00) - biospace.com/
BBIO | $24.74 -0.84% -0.85% 2M
|
Health Technology
|
| O: -1.47%
H: 2.05%
C: -0.59%
nulibry authorization treatment for therapeutics
New Topline Efficacy Data from the enVVeno Medical VenoValve(R) Pivotal Trial to be Presented at the 46th Annual Charing Cross Symposium on April 24, 2024
Published: 2024-04-16 (Crawled : 14:00) - biospace.com/
NVNO | $4.65 -2.72% -2.8% 71K
|
Manufacturing
|
| O: -1.22%
H: 0.0%
C: -2.06%
symposium topline medical trial
Cutera® Announces the North America Launch of xeo®+
Published: 2024-04-11 (Crawled : 21:00) - biospace.com/
CUTR | $1.95 -15.22% -17.95% 1.1M
|
Health Technology
|
| O: -1.71%
H: 13.36%
C: 12.21%
cutera america
Blacksmith Medicines To Highlight Preclinical Oncology Data Demonstrating a Potent and Selective FEN1 Inhibitor Has Synergy with Multiple DDR Drug Classes at AACR Annual Meeting 2024
Published: 2024-04-10 (Crawled : 22:00) - biospace.com/
LLY | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.71%
H: 0.0%
C: 0.0%
drug preclinical meeting
MEI Pharma to Present at the Stifel 2024 Virtual Targeted Oncology Forum
Published: 2024-04-10 (Crawled : 12:30) - biospace.com/
MEIP | $3.3 1.54% 1.52% 26K
|
Health Technology
|
| O: 0.0%
H: 0.52%
C: -1.57%
pharma
QuidelOrtho Adds Fentanyl Test to Its Vitros® Systems as a MicroTip® Partnership Assay
Published: 2024-04-10 (Crawled : 12:30) - biospace.com/
QDEL M | $39.09 2.17% 2.12% 1.1M
|
Health Technology
|
| O: -2.64%
H: 2.3%
C: 1.24%
vitros partnership test assay
Tandem Diabetes Care to Announce First Quarter 2024 Financial Results on May 2, 2024
Published: 2024-04-09 (Crawled : 00:00) - biospace.com/
TNDM | $30.445 -1.57% -1.59% 990K
|
Health Technology
|
| O: 0.3%
H: 4.7%
C: 3.68%
first care diabetes financial results
Poseida Therapeutics Presents New Phase 1 Data at AACR 2024 Supporting Potential of P-BCMA-ALLO1 Allogeneic CAR-T Therapy to Benefit Broad Range of Patients with Multiple Myeloma
Published: 2024-04-08 (Crawled : 00:00) - biospace.com/
PSTX | News | $2.02 1.0% 0.99% 640K
|
Health Technology
|
| O: -0.67%
H: 0.0%
C: 0.0%
car-t therapeutics potential therapy
Thermo Fisher Scientific Launches New ENERGY STAR certified TSX Universal Series ULT Freezers to Deliver Tighter Temperature Control and Faster Recovery Times
Published: 2024-04-08 (Crawled : 14:00) - biospace.com/
TMO | News | $544.78 0.6% 0.0% 1.7M
|
Health Technology
|
| O: 0.06%
H: 0.0%
C: 0.0%
tsx energy universal control series certified star
STAAR Surgical Announces Preliminary Net Sales for First Quarter 2024
Published: 2024-04-04 (Crawled : 19:00) - biospace.com/
STAA | $46.43 -0.73% -0.73% 400K
|
Health Technology
|
| O: 12.52%
H: 6.73%
C: 3.53%
sales first
Fate Therapeutics to Present at 23rd Annual Needham Virtual Healthcare Conference
Published: 2024-04-03 (Crawled : 19:00) - biospace.com/
FATE | $4.795 -4.86% -5.11% 2.7M
|
Health Technology
|
| O: -0.29%
H: 7.52%
C: 3.39%
conference therapeutics
Longboard Pharmaceuticals to Present Late-Breaking Data from the PACIFIC Study at the American Academy of Neurology (AAN) Annual Meeting on April 15
Published: 2024-04-03 (Crawled : 19:00) - biospace.com/
LBPH | $17.48 -2.94% -3.03% 520K
|
Manufacturing
|
| O: -0.61%
H: 0.61%
C: -7.83%
pharmaceuticals meeting study
Blacksmith Medicines to Present at the 23rd Annual Needham Healthcare Conference
Published: 2024-04-03 (Crawled : 15:00) - biospace.com/
LLY | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.76%
H: 0.0%
C: 0.0%
conference
Glaukos Receives Permanent J-code for iDose® TR (travoprost intracameral implant)
Published: 2024-04-03 (Crawled : 13:00) - biospace.com/
GKOS M | $96.5 1.44% 0.0% 700K
|
Health Technology
|
| O: 0.51%
H: 8.68%
C: 4.86%
idose
Alterome Therapeutics Raises $132 Million in Series B Financing Led by Goldman Sachs Alternatives
Published: 2024-04-03 (Crawled : 11:00) - biospace.com/
GS | $404.0 0.22% 0.0% 2.8M
|
Finance
|
| O: 0.21%
H: 1.37%
C: 0.73%
million series therapeutics
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | News | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.